Akanda Corp. (NASDAQ:AKAN – Get Free Report) was the target of a large growth in short interest in the month of June. As of June 15th, there was short interest totaling 139,841 shares, a growth of 84.5% from the May 31st total of 75,809 shares. Approximately 32.4% of the shares of the company are sold short. Based on an average trading volume of 535,872 shares, the short-interest ratio is presently 0.3 days.
Akanda Price Performance
Shares of NASDAQ:AKAN opened at $13.62 on Thursday. The stock’s 50-day simple moving average is $19.29 and its two-hundred day simple moving average is $10.94. Akanda has a 52-week low of $2.30 and a 52-week high of $209.02.
Wall Street Analyst Weigh In
AKAN has been the subject of a number of research analyst reports. Wall Street Zen upgraded shares of Akanda to a “sell” rating in a research note on Saturday, May 30th. Weiss Ratings downgraded shares of Akanda from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Monday, May 18th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, Akanda currently has a consensus rating of “Sell”.
About Akanda
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Read More
- Five stocks we like better than Akanda
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for Akanda Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akanda and related companies with MarketBeat.com's FREE daily email newsletter.
